Free Trial
OTCMKTS:MKGAF

Merck KGaA (MKGAF) Stock Price, News & Analysis

Merck KGaA logo
$131.88 +5.37 (+4.25%)
As of 07/16/2025 11:43 AM Eastern

About Merck KGaA Stock (OTCMKTS:MKGAF)

Key Stats

Today's Range
$131.88
$131.88
50-Day Range
$124.46
$142.99
52-Week Range
$118.05
$200.56
Volume
10 shs
Average Volume
1,052 shs
Market Capitalization
$17.04 billion
P/E Ratio
20.13
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Strong Buy

Company Overview

Merck KGaA Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
39th Percentile Overall Score

MKGAF MarketRank™: 

Merck KGaA scored higher than 39% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Earnings Growth

    Earnings for Merck KGaA are expected to grow by 8.21% in the coming year, from $9.75 to $10.55 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Merck KGaA is 20.13, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 26.66.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Merck KGaA is 20.13, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 28.15.

  • Price to Book Value per Share Ratio

    Merck KGaA has a P/B Ratio of 0.62. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Merck KGaA's valuation and earnings.
  • Percentage of Shares Shorted

    0.43% of the float of Merck KGaA has been sold short.
  • Short Interest Ratio / Days to Cover

    Merck KGaA has a short interest ratio ("days to cover") of 122.4, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Merck KGaA has recently decreased by 6.47%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Merck KGaA does not currently pay a dividend.

  • Dividend Growth

    Merck KGaA does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.43% of the float of Merck KGaA has been sold short.
  • Short Interest Ratio / Days to Cover

    Merck KGaA has a short interest ratio ("days to cover") of 122.4, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Merck KGaA has recently decreased by 6.47%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Merck KGaA has a news sentiment score of 1.02. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Merck KGaA this week, compared to 1 article on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Merck KGaA insiders have not sold or bought any company stock.

  • Percentage Held by Institutions

    Only 0.10% of the stock of Merck KGaA is held by institutions.

  • Read more about Merck KGaA's insider trading history.
Receive MKGAF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Merck KGaA and its competitors with MarketBeat's FREE daily newsletter.

MKGAF Stock News Headlines

Forget Nvidia, This “Ghost Town” Company Holds the Key to the AI Boom
Cold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to investigate this crazy Cold War story… Because it could hold the key to the entire $100 trillion AI boom. It involves an American ghost town with just 30 people… And a new twist to the AI boom that could make a lot of people rich.
See More Headlines

MKGAF Stock Analysis - Frequently Asked Questions

Merck KGaA's stock was trading at $151.56 on January 1st, 2025. Since then, MKGAF stock has decreased by 13.0% and is now trading at $131.8750.

Shares of MKGAF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
7/17/2025
Next Earnings (Estimated)
8/07/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
OTCMKTS:MKGAF
CIK
N/A
Employees
62,908
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
$6.81
Trailing P/E Ratio
20.13
Forward P/E Ratio
13.53
P/E Growth
N/A
Net Income
$3.06 billion
Net Margins
12.60%
Pretax Margin
15.64%
Return on Equity
10.17%
Return on Assets
5.74%

Debt

Debt-to-Equity Ratio
0.27
Current Ratio
1.31
Quick Ratio
0.84

Sales & Book Value

Annual Sales
$22.72 billion
Price / Sales
0.75
Cash Flow
$39.72 per share
Price / Cash Flow
3.32
Book Value
$212.00 per share
Price / Book
0.62

Miscellaneous

Outstanding Shares
129,240,000
Free Float
N/A
Market Cap
$17.04 billion
Optionable
Not Optionable
Beta
0.96

Social Links

Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

This page (OTCMKTS:MKGAF) was last updated on 7/17/2025 by MarketBeat.com Staff
From Our Partners